Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study

IF 9.9 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Cardiac Failure Pub Date : 2026-10-01 Epub Date: 2026-03-01 DOI:10.1016/j.cardfail.2026.02.035

OLIVES NGUYEN MD, MA, JACK WIEDRICK MS, MA, DANIELE MASSERA MD, ELIZABETH ADLESTEIN MD, SUMAR FREJAT MD, MATTEO CASTRICHINI MD, SAID ALSIDAWI MD, JOHN R. GIUDICESSI MD, PhD, JEFFREY B. GESKE MD, RICHARD T. CARRICK MD, JOSE MADRAZO MD, NICOLE DELLISE DNP, MARK A. ZENKER MD, THOMAS A. BOYLE MD, NOSHEEN REZA MD, ANJALI TIKU OWENS MD, DAVID S. FRANKEL, PRABHJOT HUNDAL MD, JAMIL TAJIK MD, PATRYCJA GALAZKA MD, AHMAD MASRI MD, MS

引用次数: 0

查看原文本刊更多论文

阻塞性肥厚性心肌病患者接受马伐卡坦治疗心房颤动和收缩功能障碍的发生率和结局：一项多中心研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cardiac Failure 医学-心血管系统

CiteScore

7.80

自引率

8.30%

发文量

653

审稿时长

21 days

期刊介绍： Journal of Cardiac Failure publishes original, peer-reviewed communications of scientific excellence and review articles on clinical research, basic human studies, animal studies, and bench research with potential clinical applications to heart failure - pathogenesis, etiology, epidemiology, pathophysiological mechanisms, assessment, prevention, and treatment.